Bank of New York Mellon Corp Cuts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bank of New York Mellon Corp decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 20.9% during the 4th quarter, Holdings Channel reports. The fund owned 4,439 shares of the exchange traded fund’s stock after selling 1,176 shares during the quarter. Bank of New York Mellon Corp’s holdings in SPDR S&P Biotech ETF were worth $400,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Howard Capital Management Group LLC raised its position in SPDR S&P Biotech ETF by 2.6% in the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after acquiring an additional 6,188 shares in the last quarter. Kingsview Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 8.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 3,962 shares of the exchange traded fund’s stock worth $391,000 after purchasing an additional 299 shares during the period. Private Trust Co. NA grew its stake in shares of SPDR S&P Biotech ETF by 476.3% during the 3rd quarter. Private Trust Co. NA now owns 2,916 shares of the exchange traded fund’s stock worth $288,000 after purchasing an additional 2,410 shares during the period. FMR LLC increased its holdings in shares of SPDR S&P Biotech ETF by 13.6% in the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after purchasing an additional 830 shares in the last quarter. Finally, Glenmede Trust Co. NA lifted its stake in shares of SPDR S&P Biotech ETF by 3.6% in the third quarter. Glenmede Trust Co. NA now owns 6,893 shares of the exchange traded fund’s stock valued at $681,000 after purchasing an additional 239 shares during the period.

SPDR S&P Biotech ETF Trading Down 1.3 %

XBI stock opened at $84.40 on Friday. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The company has a market cap of $5.47 billion, a P/E ratio of 11.47 and a beta of 0.99. The company’s 50-day moving average price is $89.40 and its 200 day moving average price is $93.97.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.